Home » BioCryst’s Korean Partner Receives Emergency Use Authorization
BioCryst’s Korean Partner Receives Emergency Use Authorization
BioCryst Pharmaceuticals is a development-stage biotech company
that will report over $30 million in sales in the December 2009 quarter.
Seeking Alpha
Seeking Alpha
Upcoming Events
-
07May
-
14May
-
30May